Sacubitril-valsartan versus enalapril for acute decompensated heart failure: a cost-effectiveness analysis.

Abstract:

BACKGROUND:The Comparison of Sacubitril-Valsartan versus Enalapril on Effect on NT-proBNP in Patients Stabilised from an Acute Heart Failure Episode (PIONEER-HF) trial demonstrated significant reductions in N-terminal pro-B-type natriuretic peptide. Our study explored the cost-effectiveness of the use of sacubitril-valsartan versus enalapril in acute decompensated heart failure from the Australian healthcare perspective. METHODS:A Markov model was designed using data from the PIONEER-HF trial to model the clinical progress and costs of patients over a lifetime time horizon. The model consisted of three health states: 'alive and event-free', 'alive after non-fatal hospitalisation for acute decompensated heart failure' or 'dead'. Costs and utilities were estimated from published sources. The cost of sacubitril-valsartan (per the Australian pharmaceutical benefits schedule) was AU$7.08/day. Outcomes of interest were the incremental cost-effectiveness ratios in terms of cost per quality-adjusted life year gained and cost per year of life saved. Cost and benefits were discounted at 5.0% per annum. RESULTS:Compared to enalapril, sacubitril-valsartan was estimated to cost an additional AU$7464 (discounted) per person, but lead to 0.127 years of life saved (discounted) and 0.096 quality-adjusted life years gained (discounted) over a lifetime analysis. These equated to incremental cost-effectiveness ratios of AU$58,629/year of life saved (US$41,795, EU€58,629, GBP£32,001) and AU$77,889/quality-adjusted life year gained (US$55,526, EU€49,202, GBP£42,504). We have assumed a threshold of AU$50,000/quality-adjusted life year gained to suggest cost-effectiveness. CONCLUSIONS:At its current acquisition price, sacubitril-valsartan in comparison to enalapril is not likely to be cost-effective in the management of acute decompensated heart failure in Australia. A price reduction of more than 25% would confer cost-effectiveness.

journal_name

Eur J Prev Cardiol

authors

Perera K,Ademi Z,Liew D,Zomer E

doi

10.1177/2047487319878953

subject

Has Abstract

pub_date

2019-10-04 00:00:00

pages

2047487319878953

eissn

2047-4873

issn

2047-4881

pub_type

杂志文章
  • Treat-to-target versus dose-adapted statin treatment of cholesterol to reduce cardiovascular risk.

    abstract::Clinical guidelines should be based on the best available evidence and are of great importance for patient care and disease prevention. In this respect, the 2013 American College of Cardiology/American Heart Association report is highly appreciated and well-recognized. The report included critical questions concerning...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487314567001

    authors: Müller-Wieland D,Assmann G,Carmena R,Davignon J,von Eckardstein A,Farinaro E,Greten H,Olsson AG,Riesen WF,Shlyakhto E

    更新日期:2016-02-01 00:00:00

  • Caffeine intake reduces incident atrial fibrillation at a population level.

    abstract::Background The general belief is that caffeine increases the risk of hyperkinetic arrhythmias, including atrial fibrillation. The aim of this study is to investigate the effect of chronic caffeine intake on incident atrial fibrillation in general population. Design and methods A population cohort of 1475 unselected me...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487318772945

    authors: Casiglia E,Tikhonoff V,Albertini F,Gasparotti F,Mazza A,Montagnana M,Danese E,Benati M,Spinella P,Palatini P

    更新日期:2018-07-01 00:00:00

  • Predictive and explanatory factors of cardiovascular disease in people with adequately controlled type 2 diabetes.

    abstract::Aims To explore the predictive and explanatory factors on the incidence of cardiovascular disease and the impact of visit-to-visit variability (VVV) of risk factors on incident cardiovascular disease in people with type 2 diabetes with no history of prior cardiovascular disease. Methods We performed a historical cohor...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487317707293

    authors: Hashemi Madani N,Ismail-Beigi F,Khamseh ME,Malek M,Ebrahimi Valojerdi A

    更新日期:2017-07-01 00:00:00

  • Statin tolerability: In defence of placebo-controlled trials.

    abstract:BACKGROUND:Statin intolerance is a barrier to effective lipid-lowering treatment. A significant number of patients stop prescribed statins, or can take only a reduced dose, because of adverse events attributed to the statin, and are then considered statin-intolerant. METHODS:Examination of differences between statin a...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章,评审

    doi:10.1177/2047487315602861

    authors: Tobert JA,Newman CB

    更新日期:2016-05-01 00:00:00

  • Transgenerational effects of parental cardiovascular disease and risk factors on offspring mortality: family-linkage data from the HUNT Study, Norway.

    abstract:BACKGROUND:Cardiovascular risk factors are known to be associated between parents and offspring. However, whether these associations are reflected in increased offspring mortality has not been extensively studied. DESIGN:This was a family study of 32,536 father-offspring and 39,614 mother-offspring pairs who participa...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487314562118

    authors: Vik KL,Romundstad P,Carslake D,Davey Smith G,Nilsen TI

    更新日期:2016-01-01 00:00:00

  • Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial.

    abstract:BACKGROUND:The complexity of treatment regimens, costs and pill burden decrease the medication adherence and contribute to shortfall in cardiovascular preventive drug coverage. The polypill, a fixed dose combination pill of established drugs, is expected to increase adherence and reduce the costs whilst preventing majo...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1177/2047487314550803

    authors: Ostovaneh MR,Poustchi H,Hemming K,Marjani H,Pourshams A,Nateghi A,Majed M,Navabakhsh B,Khoshnia M,Jaafari E,Mohammadifard N,Malekzadeh F,Merat S,Sadeghi M,Naemi M,Etemadi A,Thomas GN,Sarrafzadegan N,Cheng KK,Marshal

    更新日期:2015-12-01 00:00:00

  • Exercise training improves neurovascular control and functional capacity in heart failure patients regardless of age.

    abstract:BACKGROUND:Exercise training is a non-pharmacological strategy for treatment of heart failure. Exercise training improves functional capacity and quality of life in patients. Moreover, exercise training reduces muscle sympathetic nerve activity (MSNA) and peripheral vasoconstriction. However, most of these studies have...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/1741826711414626

    authors: Antunes-Correa LM,Kanamura BY,Melo RC,Nobre TS,Ueno LM,Franco FG,Roveda F,Braga AM,Rondon MU,Brum PC,Barretto AC,Middlekauff HR,Negrao CE

    更新日期:2012-08-01 00:00:00

  • Prescribing, dosing and titrating exercise in patients with hypertrophic cardiomyopathy for prevention of comorbidities: Ready for prime time.

    abstract::The benefits of physical activity are well established, leading to both cardiovascular and non-cardiovascular benefits, improving quality of life and reducing mortality. Despite such striking body of evidence, patients with hypertrophic cardiomyopathy are often discouraged by health professionals to practice physical a...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487320928654

    authors: Cavigli L,Olivotto I,Fattirolli F,Mochi N,Favilli S,Mondillo S,Bonifazi M,D'Ascenzi F

    更新日期:2020-06-17 00:00:00

  • Serum tissue-degrading proteinases and incident cardiovascular disease events.

    abstract:BACKGROUND:Extracellular matrix-degrading proteinases are upregulated in atherosclerotic lesions and can contribute to subsequent pathological events. In the present nested case-control study, we investigated the association of serum concentrations of matrix metalloproteinases MMP-7, MMP-8, and MMP-13, tissue inhibitor...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487312465524

    authors: Tuomainen AM,Kormi I,Havulinna AS,Tervahartiala T,Salomaa V,Sorsa T,Pussinen PJ

    更新日期:2014-07-01 00:00:00

  • High prevalence of congenital heart disease at high altitudes in Tibet.

    abstract:BACKGROUND:Previous small sample studies suggested that elevated altitudes might be associated with the incidence of cardiovascular diseases. However, it remains uncertain whether high altitudes (over 3000 m above sea level) are related to congenital heart disease. We therefore explored the prevalence of congenital hea...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487318812502

    authors: Chun H,Yue Y,Wang Y,Dawa Z,Zhen P,La Q,Zong Y,Qu Y,Mu D

    更新日期:2019-05-01 00:00:00

  • Calculated and perceived cardiovascular risk in asymptomatic subjects submitted to a routine medical evaluation: The perception gap.

    abstract:BACKGROUND:Poor adherence to medical treatment represents a major health problem. A subject's misperception of his own cardiovascular risk has been indicated as a key driver for low compliance with preventive measures. This study analysed the relationship between objectively calculated short- and long-term cardiovascul...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487314543074

    authors: Katz M,Laurinavicius AG,Franco FG,Conceicao RD,Carvalho JA,Pesaro AE,Wajngarten M,Santos RD

    更新日期:2015-08-01 00:00:00

  • Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.

    abstract::Numerous molecular screening strategies have recently been developed to measure the chemical diversity of a population's biofluids with the ultimate aim to provide clinicians, medical scientists and epidemiologists with a clearer picture of the presence and severity of cardiovascular disease; prognosis; and response t...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章,评审

    doi:10.1177/2047487316645469

    authors: Dona AC,Coffey S,Figtree G

    更新日期:2016-10-01 00:00:00

  • Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.

    abstract:AIMS:To determine the effect of ticagrelor compared to clopidogrel in patients with peripheral artery disease (PAD) and acute coronary syndromes (ACS). METHODS AND RESULTS:PLATO (n = 18,624) was a multicentre, double-blind, randomized trial in ACS, that showed a 16% reduction in cardiovascular death (CV-death), myocar...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1177/2047487314533215

    authors: Patel MR,Becker RC,Wojdyla DM,Emanuelsson H,Hiatt WR,Horrow J,Husted S,Mahaffey KW,Steg PG,Storey RF,Wallentin L,James SK

    更新日期:2015-06-01 00:00:00

  • Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia.

    abstract:OBJECTIVE:To determine the cost-effectiveness of apixaban versus warfarin in patients with atrial fibrillation (AF) with a moderate to severe risk of stroke, from an Australian government-perspective. METHODS:A decision-analytic Markov model was constructed to assess the cost-effectiveness of apixaban versus warfarin,...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487313514019

    authors: Ademi Z,Pasupathi K,Liew D

    更新日期:2015-03-01 00:00:00

  • Risk factor levels, risk factor combinations, and residual coronary risk: population-based estimates for secondary prevention patients using statins.

    abstract:BACKGROUND:Population-based risk factor combinations and residual risks for coronary heart disease (CHD) patients on statins were assessed in order to bridge the gap between knowledge on relative effects from clinical trials and absolute risk from real-world practice. DESIGN:Population-based, retrospective 1-year cros...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/1741826710392668

    authors: Krobot KJ,Wagner A,Siebert U

    更新日期:2012-02-01 00:00:00

  • Sesame oil consumption exerts a beneficial effect on endothelial function in hypertensive men.

    abstract:BACKGROUND:The aim of the study was to investigate the effects of sesame oil on endothelial function and to detect the underlying mechanisms, both in the postprandial state and after long-term consumption. DESIGN:We enrolled 30 hypertensive men in a two-phase study. In the first phase, 26 volunteers consumed 35 g of e...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487312437625

    authors: Karatzi K,Stamatelopoulos K,Lykka M,Mantzouratou P,Skalidi S,Zakopoulos N,Papamichael C,Sidossis LS

    更新日期:2013-04-01 00:00:00

  • Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and Europe.

    abstract::The use of preventive medications in people at high risk of cardiovascular disease is conceptually straightforward, yet in practice the adoption of such measures is disappointingly low, plus there is wide international variation in preventive therapies. Several barriers might explain this shortfall and variation, but ...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1177/2047487312463278

    authors: Thom S,Field J,Poulter N,Patel A,Prabhakaran D,Stanton A,Grobbee DE,Bots ML,Reddy KS,Cidambi R,Rodgers A

    更新日期:2014-02-01 00:00:00

  • Ability to sit and rise from the floor as a predictor of all-cause mortality.

    abstract:BACKGROUND:While cardiorespiratory fitness is strongly related to survival, there are limited data regarding musculoskeletal fitness indicators. Our aim was to evaluate the association between the ability to sit and rise from the floor and all-cause mortality. DESIGN:Retrospective cohort. METHODS:2002 adults aged 51-...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487312471759

    authors: Brito LB,Ricardo DR,Araújo DS,Ramos PS,Myers J,Araújo CG

    更新日期:2014-07-01 00:00:00

  • Predictors of pre-rehabilitation exercise capacity in elderly European cardiac patients - The EU-CaRE study.

    abstract:AIMS:Functional capacity is an important endpoint for therapies oriented to older adults with cardiovascular diseases. The literature on predictors of exercise capacity is sparse in the elderly population. In a longitudinal European study on effectiveness of cardiac rehabilitation of seven European countries in elderly...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487319894676

    authors: Marcin T,Eser P,Prescott E,Mikkelsen N,Prins LF,Kolkman EK,Lado-Baleato Ó,Cardaso-Suaréz C,Bruins W,van der Velde AE,Peña Gil C,Iliou MC,Ardissino D,Zeymer U,Meindersma EP,Van't Hof AW,de Kluiver EP,Wilhelm M

    更新日期:2020-11-01 00:00:00

  • Impaired vascular function and repair in patients with premature coronary artery disease.

    abstract:BACKGROUND:Endothelial dysfunction is central to the pathogenesis of coronary artery disease, but the role of local and circulating endothelial progenitor cells in maintaining vascular health is poorly understood. We hypothesised that impaired local and circulating vascular repair mechanisms predispose to endothelial d...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487315600169

    authors: Brittan M,Hunter A,Boulberdaa M,Fujisawa T,Skinner EM,Shah AS,Baker AH,Mills NL

    更新日期:2015-12-01 00:00:00

  • The HeartQoL: part II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease.

    abstract:BACKGROUND:Evaluation of health-related quality of life (HRQL) is important in improving the quality of patient care. The aim of this study was to determine the psychometric properties of the HeartQoL in patients with ischemic heart disease (IHD), specifically angina, myocardial infarction (MI), or ischemic heart failu...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1177/2047487312450545

    authors: Oldridge N,Höfer S,McGee H,Conroy R,Doyle F,Saner H,(for the HeartQoL Project Investigators).

    更新日期:2014-01-01 00:00:00

  • Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis.

    abstract:BACKGROUND:The incidence of metabolic syndrome (MetS), diabetes mellitus (DM), and their coexistence is increasing but whether MetS increases cardiovascular risk beyond component risk factors is controversial. DESIGN:We compared the risk of cardiovascular death, myocardial infarction, or stroke among patients with Met...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1177/2047487313500541

    authors: Udell JA,Steg PG,Scirica BM,Eagle KA,Ohman EM,Goto S,Alsheikh-Ali AA,Porath A,Corbalan R,Umez-Eronini AA,Hoffman EB,Wilson PW,Bhatt DL,Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators.

    更新日期:2014-12-01 00:00:00

  • The case for extended thromboprophylaxis in medically hospitalised patients - not yet made.

    abstract:BACKGROUND:The role of extended thromboprophylaxis is established for surgical patients, but not yet for hospitalised medical patients. DESIGN:This systematic review and meta-analysis sought to explore the role of extended thromboprophylaxis for medically ill hospitalised patients. METHODS:Medline, EMBASE and Cochran...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487319836572

    authors: Cao JY,Lee SY,Dunkley S,Adams M,Keech A

    更新日期:2019-03-16 00:00:00

  • Age and gender differences in incidence and case fatality trends for myocardial infarction: a 30-year follow-up. The Tromso Study.

    abstract:BACKGROUND:Although the mortality of coronary heart disease (CHD) has declined in Western countries during the last decades, studies have suggested that the prevention and treatment of CHD may not have been as effective in women as in men. We examined gender- and age-specific trends in incidence, case fatality and the ...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/1741826711421081

    authors: Mannsverk J,Wilsgaard T,Njølstad I,Hopstock LA,Løchen ML,Mathiesen EB,Thelle DS,Rasmussen K,Bønaa KH

    更新日期:2012-10-01 00:00:00

  • Of heart and kidney: a complicated love story.

    abstract::The multiple connections that exist between the cardiovascular system and the kidney lead to a complex cardiovascular and renal medicine relationship. It is well established in the literature that chronic kidney disease (CKD) is an important and independent risk factor for cardiovascular disease (CVD). The prevalence ...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章,评审

    doi:10.1177/2047487312462826

    authors: Gaita D,Mihaescu A,Schiller A

    更新日期:2014-07-01 00:00:00

  • Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study.

    abstract:OBJECTIVES:To assess the practices of physicians in 12 European countries in the primary prevention of cardiovascular disease (CVD). METHODS:In 2009, 806 physicians from 12 European countries answered a questionnaire, delivered electronically or by post, regarding their assessment of patients with cardiovascular risk ...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1177/1741826711407705

    authors: Dallongeville J,Banegas JR,Tubach F,Guallar E,Borghi C,De Backer G,Halcox JP,Massó-González EL,Perk J,Sazova O,Steg PG,Artalejo FR,EURIKA Investigators.

    更新日期:2012-06-01 00:00:00

  • Extracellular matrix markers and risk of myocardial infarction: The HUNT Study in Norway.

    abstract::Aims Extracellular matrix remodelling may influence atherosclerotic progression and plaque stability. We hypothesized that evaluation of extracellular matrix markers, with potentially different roles during atherogenesis, could provide information on underlying mechanisms and risk of myocardial infarction (MI) in appa...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1177/2047487317703826

    authors: Ueland T,Laugsand LE,Vatten LJ,Janszky I,Platou C,Michelsen AE,Damås JK,Aukrust P,Åsvold BO

    更新日期:2017-07-01 00:00:00

  • Heart failure and its complications in patients with diabetes: Mounting evidence for a growing burden.

    abstract::Heart failure (HF) is one of the major challenges in the management of diabetes patients. Among subjects with diabetes, up to 20% could have HF. Conversely, diabetes prevalence in HF patients varies greatly from more than 10% up to 50%. When it is present, the risk of mortality and rehospitalization increases substant...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章,评审

    doi:10.1177/2047487319885461

    authors: Ferrini M,Johansson I,Aboyans V

    更新日期:2019-12-01 00:00:00

  • Persistent emotional distress after a first-time myocardial infarction and its association to late cardiovascular and non-cardiovascular mortality.

    abstract:BACKGROUND:Patients with symptoms of depression and/or anxiety - emotional distress - after a myocardial infarction (MI) have been shown to have worse prognosis and increased healthcare costs. However, whether specific subgroups of patients with emotional distress are more vulnerable is less well established. The purpo...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章

    doi:10.1177/2047487319841475

    authors: Lissåker CT,Norlund F,Wallert J,Held C,Olsson EM

    更新日期:2019-09-01 00:00:00

  • Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis.

    abstract::Background In contemporary atrial fibrillation trials most deaths are cardiac related, whereas stroke and bleeding represent only a small subset of deaths. We aimed to evaluate the long-term risk of cardiac events and all-cause mortality in individuals with atrial fibrillation compared to no atrial fibrillation. Desig...

    journal_title:European journal of preventive cardiology

    pub_type: 杂志文章,meta分析,评审

    doi:10.1177/2047487317715769

    authors: Ruddox V,Sandven I,Munkhaugen J,Skattebu J,Edvardsen T,Otterstad JE

    更新日期:2017-09-01 00:00:00